SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 91 filers reported holding SCHOLAR ROCK HLDG CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,471,745 | +16.2% | 207,288 | +23.3% | 0.00% | – |
| Q2 2023 | $1,267,104 | +636.7% | 168,051 | +435.0% | 0.00% | – |
| Q2 2022 | $172,000 | -86.8% | 31,409 | -70.9% | 0.00% | – |
| Q1 2022 | $1,304,000 | -48.7% | 107,787 | +5.3% | 0.00% | -100.0% |
| Q4 2021 | $2,542,000 | +100.6% | 102,317 | +10.7% | 0.00% | – |
| Q3 2021 | $1,267,000 | -3.1% | 92,403 | -3.0% | 0.00% | – |
| Q2 2021 | $1,307,000 | -17.2% | 95,257 | -17.1% | 0.00% | -100.0% |
| Q1 2021 | $1,578,000 | -0.1% | 114,963 | -0.2% | 0.00% | 0.0% |
| Q4 2020 | $1,580,000 | -27.4% | 115,227 | -6.3% | 0.00% | 0.0% |
| Q3 2020 | $2,175,000 | -4.2% | 122,923 | -1.4% | 0.00% | 0.0% |
| Q2 2020 | $2,270,000 | +88.7% | 124,618 | +25.4% | 0.00% | 0.0% |
| Q1 2020 | $1,203,000 | +113.3% | 99,355 | +132.5% | 0.00% | – |
| Q4 2019 | $564,000 | +10.8% | 42,741 | -24.9% | 0.00% | – |
| Q3 2019 | $509,000 | -48.0% | 56,923 | -7.7% | 0.00% | – |
| Q2 2019 | $979,000 | – | 61,696 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
| Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
| Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
| Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
| Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
| Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
| Atom Investors LP | 25,839 | $333,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
| Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
| Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |